Xovia Eye Drop BAK Free contains Nepafenac 0.1% w/v, a nonsteroidal anti-inflammatory drug (NSAID) specifically formulated for ophthalmic use. Nepafenac acts by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins responsible for inflammation and pain in ocular tissues. This formulation is preservative-free, eliminating benzalkonium chloride (BAK), which is known to cause ocular surface irritation and dryness, making it suitable for patients with sensitive eyes or those requiring long-term therapy. Xovia Eye Drop BAK Free is primarily indicated for the management of postoperative inflammation and pain following cataract surgery. It may also be used to reduce the risk of macular edema associated with cataract extraction in diabetic patients. The drug is administered topically, allowing targeted delivery to the anterior segment of the eye, ensuring rapid onset of action and minimal systemic absorption. Patients should use the drops as prescribed, typically one drop three times daily starting one day before surgery and continuing for up to two weeks postoperatively. Caution is advised in patients with known hypersensitivity to nepafenac or other NSAIDs. Proper administration technique and adherence to dosing schedule are essential to optimize therapeutic outcomes and minimize adverse effects.